Report Detail

Pharma & Healthcare COVID-19 Impact on Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2026

  • RnM4062925
  • |
  • 16 June, 2020
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

SPECT Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global SPECT Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the SPECT Radiopharmaceuticals market is segmented into
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other

Segment by Application, the SPECT Radiopharmaceuticals market is segmented into
Oncology
Cardiology
Thyroid

Regional and Country-level Analysis
The SPECT Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the SPECT Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and SPECT Radiopharmaceuticals Market Share Analysis
SPECT Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in SPECT Radiopharmaceuticals business, the date to enter into the SPECT Radiopharmaceuticals market, SPECT Radiopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
...


1 Study Coverage

  • 1.1 SPECT Radiopharmaceuticals Product Introduction
  • 1.2 Market Segments
  • 1.3 Key SPECT Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type
    • 1.4.2 Technetium-99
    • 1.4.3 Thallium-201
    • 1.4.4 Gallium-67
    • 1.4.5 Iodine-123
    • 1.4.6 Indium-111
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Cardiology
    • 1.5.4 Thyroid
  • 1.6 Coronavirus Disease 2019 (Covid-19): SPECT Radiopharmaceuticals Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the SPECT Radiopharmaceuticals Industry
      • 1.6.1.1 SPECT Radiopharmaceuticals Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and SPECT Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for SPECT Radiopharmaceuticals Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global SPECT Radiopharmaceuticals Market Size Estimates and Forecasts
    • 2.1.1 Global SPECT Radiopharmaceuticals Revenue 2015-2026
    • 2.1.2 Global SPECT Radiopharmaceuticals Sales 2015-2026
  • 2.2 SPECT Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global SPECT Radiopharmaceuticals Competitor Landscape by Players

  • 3.1 SPECT Radiopharmaceuticals Sales by Manufacturers
    • 3.1.1 SPECT Radiopharmaceuticals Sales by Manufacturers (2015-2020)
    • 3.1.2 SPECT Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
  • 3.2 SPECT Radiopharmaceuticals Revenue by Manufacturers
    • 3.2.1 SPECT Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
    • 3.2.2 SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global SPECT Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by SPECT Radiopharmaceuticals Revenue in 2019
    • 3.2.5 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 SPECT Radiopharmaceuticals Price by Manufacturers
  • 3.4 SPECT Radiopharmaceuticals Manufacturing Base Distribution, Product Types
    • 3.4.1 SPECT Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers SPECT Radiopharmaceuticals Product Type
    • 3.4.3 Date of International Manufacturers Enter into SPECT Radiopharmaceuticals Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global SPECT Radiopharmaceuticals Market Size by Type (2015-2020)
    • 4.1.1 Global SPECT Radiopharmaceuticals Sales by Type (2015-2020)
    • 4.1.2 Global SPECT Radiopharmaceuticals Revenue by Type (2015-2020)
    • 4.1.3 SPECT Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global SPECT Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Type (2021-2026)
    • 4.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
    • 4.2.3 SPECT Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global SPECT Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global SPECT Radiopharmaceuticals Market Size by Application (2015-2020)
    • 5.1.1 Global SPECT Radiopharmaceuticals Sales by Application (2015-2020)
    • 5.1.2 Global SPECT Radiopharmaceuticals Revenue by Application (2015-2020)
    • 5.1.3 SPECT Radiopharmaceuticals Price by Application (2015-2020)
  • 5.2 SPECT Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Application (2021-2026)
    • 5.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global SPECT Radiopharmaceuticals Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America SPECT Radiopharmaceuticals by Country
    • 6.1.1 North America SPECT Radiopharmaceuticals Sales by Country
    • 6.1.2 North America SPECT Radiopharmaceuticals Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America SPECT Radiopharmaceuticals Market Facts & Figures by Type
  • 6.3 North America SPECT Radiopharmaceuticals Market Facts & Figures by Application

7 Europe

  • 7.1 Europe SPECT Radiopharmaceuticals by Country
    • 7.1.1 Europe SPECT Radiopharmaceuticals Sales by Country
    • 7.1.2 Europe SPECT Radiopharmaceuticals Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe SPECT Radiopharmaceuticals Market Facts & Figures by Type
  • 7.3 Europe SPECT Radiopharmaceuticals Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific SPECT Radiopharmaceuticals by Region
    • 8.1.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Region
    • 8.1.2 Asia Pacific SPECT Radiopharmaceuticals Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific SPECT Radiopharmaceuticals Market Facts & Figures by Type
  • 8.3 Asia Pacific SPECT Radiopharmaceuticals Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America SPECT Radiopharmaceuticals by Country
    • 9.1.1 Latin America SPECT Radiopharmaceuticals Sales by Country
    • 9.1.2 Latin America SPECT Radiopharmaceuticals Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America SPECT Radiopharmaceuticals Market Facts & Figures by Type
  • 9.3 Central & South America SPECT Radiopharmaceuticals Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa SPECT Radiopharmaceuticals by Country
    • 10.1.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Country
    • 10.1.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa SPECT Radiopharmaceuticals Market Facts & Figures by Type
  • 10.3 Middle East and Africa SPECT Radiopharmaceuticals Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GE Healthcare
    • 11.1.1 GE Healthcare Corporation Information
    • 11.1.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GE Healthcare SPECT Radiopharmaceuticals Products Offered
    • 11.1.5 GE Healthcare Recent Development
  • 11.2 Cardinal Health
    • 11.2.1 Cardinal Health Corporation Information
    • 11.2.2 Cardinal Health Description, Business Overview and Total Revenue
    • 11.2.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Cardinal Health SPECT Radiopharmaceuticals Products Offered
    • 11.2.5 Cardinal Health Recent Development
  • 11.3 Lantheus Medical Imaging
    • 11.3.1 Lantheus Medical Imaging Corporation Information
    • 11.3.2 Lantheus Medical Imaging Description, Business Overview and Total Revenue
    • 11.3.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Products Offered
    • 11.3.5 Lantheus Medical Imaging Recent Development
  • 11.4 Bracco Imaging
    • 11.4.1 Bracco Imaging Corporation Information
    • 11.4.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.4.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Bracco Imaging SPECT Radiopharmaceuticals Products Offered
    • 11.4.5 Bracco Imaging Recent Development
  • 11.5 Eczacibasi-Monrol Nuclear Products
    • 11.5.1 Eczacibasi-Monrol Nuclear Products Corporation Information
    • 11.5.2 Eczacibasi-Monrol Nuclear Products Description, Business Overview and Total Revenue
    • 11.5.3 Eczacibasi-Monrol Nuclear Products Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Products Offered
    • 11.5.5 Eczacibasi-Monrol Nuclear Products Recent Development
  • 11.6 IBA Molecular Imaging
    • 11.6.1 IBA Molecular Imaging Corporation Information
    • 11.6.2 IBA Molecular Imaging Description, Business Overview and Total Revenue
    • 11.6.3 IBA Molecular Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Products Offered
    • 11.6.5 IBA Molecular Imaging Recent Development
  • 11.7 Jubilant Life Sciences
    • 11.7.1 Jubilant Life Sciences Corporation Information
    • 11.7.2 Jubilant Life Sciences Description, Business Overview and Total Revenue
    • 11.7.3 Jubilant Life Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Products Offered
    • 11.7.5 Jubilant Life Sciences Recent Development
  • 11.1 GE Healthcare
    • 11.1.1 GE Healthcare Corporation Information
    • 11.1.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GE Healthcare SPECT Radiopharmaceuticals Products Offered
    • 11.1.5 GE Healthcare Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 SPECT Radiopharmaceuticals Market Estimates and Projections by Region
    • 12.1.1 Global SPECT Radiopharmaceuticals Sales Forecast by Regions 2021-2026
    • 12.1.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
  • 12.2 North America SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.2.1 North America: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.2.2 North America: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.2.3 North America: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.3 Europe SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.3.1 Europe: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.3.2 Europe: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.3.3 Europe: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: SPECT Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.5.2 Latin America: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key SPECT Radiopharmaceuticals Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 SPECT Radiopharmaceuticals Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global SPECT Radiopharmaceuticals. Industry analysis & Market Report on COVID-19 Impact on Global SPECT Radiopharmaceuticals is a syndicated market report, published as COVID-19 Impact on Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global SPECT Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,077.10
    4,615.65
    6,154.20
    3,701.10
    5,551.65
    7,402.20
    608,829.00
    913,243.50
    1,217,658.00
    329,433.00
    494,149.50
    658,866.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report